Is ARES a buy, hold, or sell?
ARES carries a valuation grade of Strong Strong Buy. The trailing P/E of 50.3 sits 259% above the Financials sector median of 14.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $105–$164 — implying a +23% margin of safety at the current price of $109.13. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 3% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter missed by a 6.6% earnings surprise. Analyst estimate revisions are trending upward.
What are ARES's key risk factors?
With a beta of 1.52, ARES exhibits a highly aggressive risk profile relative to the broad market. The 95th-percentile CVaR of -30.5% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 3.1% of total portfolio loss in the worst 5% of months. Net margins of 10.5% fall below the Financials sector average of 28%, suggesting margin pressure. Leverage is moderate with debt-to-equity at 169%.
Implied volatility of 2.5% is below realized volatility of 48.1%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $1102.8M recently. While routine dispositions are common, the magnitude bears watching. Short interest of 17.2% of float is elevated, reflecting meaningful bearish positioning.
How does ARES fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — ARES carries a beta of 1.52, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, ARES shows the strongest co-movement with KKR (0.82), BX (0.79), OWL (0.78). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.82, adding ARES to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The ARES analysis here is a single node in that larger structure.
For our full conviction hierarchy across alternative asset managers — including ARES's positioning in the 2026 private credit stress test — see: Private Equity 2026: $265B Crisis — Why Blackstone & KKR Lead. For the BDC redemption mechanics and fund-level data underpinning these ratings: Private Credit 2026: BDC Liquidity Crisis & Systemic Stress Test →
